Safety of pharmacotherapy in the elderly patients with psychiatric diseases

Kirilochev, O.O.; Умерова, А. Р.; Дорфман, И. П.; Bataeva, Svetlana E.

doi:10.32756/0869-5490-2020-1-80-84

CPT

2020

DOI: 10.32756/0869-5490-2020-1-80-84

|View full text |Cite

Safety of pharmacotherapy in the elderly patients with psychiatric diseases

O.O. Kirilochev¹,

А. Р. Умерова²,

И. П. Дорфман³

et al.

Abstract: аспекты безопасности фармако тера пии пожилых пациентов с психическими заболеваниями. Клин фармакол тер 2020;29(1):80-84 [Kirilochev OO, Umerova AR, Dorfman IP, Bataeva SE. Safety of pharmacotherapy in the elderly patients with psychiatric diseases. Klinicheskaya farmakologiya i terapiya = Clin Pharmacol Ther 2020;29(1). (In Russ.)].

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Other1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Perspectives on Using Tools to Control Polypharmacy in Psychiatric Patients

Kirilochev,

Umerova

2021

View full text Add to dashboard Cite

The study aimed to evaluate the risk of developing adverse drug reactions in patients aged 65 years and older who received drug treatment for mental disorders. The analysis demonstrated the potential of specific tools for assessing drug therapy appropriateness in a mental health setting. An assessment using «Trigger Tool for Measuring Adverse Drug Events in a Mental Health Setting» and «The GerontoNet ADR Risk Score» showed that more than half of hospitalized elderly patients are at risk of adverse reactions. In the majority of cases, this risk was associated with two major factors characterizing drug therapy in the study group: age and psychopharmacotherapy. These results highlight the importance of careful control over drug therapy safety in patients aged 65 years and older and therapy optimization when a high risk of adverse drug events is identified.

show abstract

Perspectives on Using Tools to Control Polypharmacy in Psychiatric Patients

Kirilochev,

Umerova

2021

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Safety of pharmacotherapy in the elderly patients with psychiatric diseases

Cited by 1 publication

References 22 publications

Perspectives on Using Tools to Control Polypharmacy in Psychiatric Patients

Perspectives on Using Tools to Control Polypharmacy in Psychiatric Patients

Contact Info

Product

Resources

About